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Abstract
Most Western health systems remain single illness orientated despite the growing prevalence of multi-morbidity. Identifying
how much time people with multiple chronic conditions spend managing their health will help policy makers and health
service providers make decisions about areas of patient need for support. This article presents findings from an Australian
study concerning the time spent on health related activity by older adults (aged 50 years and over), most of whom had
multiple chronic conditions. A recall questionnaire was developed, piloted, and adjusted. Sampling was undertaken through
three bodies; the Lung Foundation Australia (COPD sub-sample), National Diabetes Services Scheme (Diabetes sub-sample)
and National Seniors Australia (Seniors sub-sample). Questionnaires were mailed out during 2011 to 10,600 older adults
living in Australia. 2540 survey responses were received and analysed. Descriptive analyses were completed to obtain
median values for the hours spent on each activity per month. The mean number of chronic conditions was 3.7 in the COPD
sub-sample, 3.4 in the Diabetes sub-sample and 2.0 in the NSA sub-sample. The study identified a clear trend of increased
time use associated with increased number of chronic conditions. Median monthly time use was 5–16 hours per month
overall for our three sub-samples. For respondents in the top decile with five or more chronic conditions the median time
use was equivalent to two to three hours per day, and if exercise is included in the calculations, respondents spent from
between five and eight hours per day: an amount similar to full-time work. Multi-morbidity imposes considerable time
burdens on patients. Ageing is associated with increasing rates of multi-morbidity. Many older adults are facing high
demands on their time to manage their health in the face of decreasing energy and mobility. Their time use must be
considered in health service delivery and health system reform.
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Introduction
Research on multi-morbidity (defined as the presence of two or
more chronic conditions in an individual [1]) has shown an
increase in its prevalence over the last decade in Australia and
elsewhere [2,3,4]. Recent research has focused on tracking
patterns of multi-morbidity [2,3,4], prescription medication issues
[5,6,7], the complexity of providing primary care [2,5,8,9,10], co-
ordination [11] and self-management [12,13].
There is a gap in our knowledge of how people with multi-
morbid chronic conditions (multi-morbidity hereafter) use time
when undertaking health related activity (HRA). Recently
Krueger noted that ‘‘Failing to take account of patient time
leads us to exaggerate the productivity of the health care sector,
and to underestimate the cost of health care’’ [14]. Drawing on
the American Time Use Survey, he estimates that in 2007,
Americans spent an average of 1.1 hours each week obtaining
healthcare. This time, he argues, is an unseen cost in health
care [15,16,17]. Other studies have measured the use of time as
an unseen cost in health care [15,16,17]. Large surveys such as
the American and Australian time use surveys provide limited
detail about the time people spend on HRA. Current health
care models and clinical guidelines can pose unrealistic
expectations in terms of the burden of self-management for
people with multi-morbidity; who may be prescribed multiple
doses of multiple medications each day, and who may also be
undertaking several non-pharmacological activities such as
exercise, or attending support groups, rehabilitation services or
health care services in any given week [18]. Research is needed
to address this gap on how people with multi-morbidity spend
their time on health care.
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Time to Manage: Priorities in Self-management and HRA
Management of chronic conditions includes self-management as
well as interactions with health services, which together comprise
HRA. Knowledge of the self-management tasks people perform
and their duration has the potential to inform the planning and
design of services to support efficient self-management and optimal
health outcomes [19], as well as contributing to an understanding
of the overall cost to the community of chronic conditions.
Self-management encompasses a range of tasks including
managing the medical aspects of the condition (taking medica-
tions, testing), maintaining or changing the ways that necessary or
meaningful tasks are completed (maintaining a healthy diet,
exercising), and coping with the emotions experienced [20,21].
Performing these tasks is time consuming [15,19] and is thought to
vary between conditions and with severity [15]. Few studies have
described the characteristics of people who are likely to spend
more or less time managing their health [19]. People with multi-
morbidity have management tasks for each condition which can
be overwhelming [18,19,22].
Patients self-manage because they live with their condition on
a daily basis and need to develop strategies to care for themselves
[23]. A certain amount of time spent on self-management of
chronic condition is inevitable and is necessary [24,25]. Some
activities such as taking prescribed medication cannot be delegated
to the system unless a person goes into formal care [12]. Growing
evidence supports the effectiveness of self-management to improve
health and quality of life outcomes for people with chronic
condition [25,26], and a range of programs are available in
Australia to support self management (for example, the Chronic
Disease Self Management Program [27] and the Flinders Program
[28]). Primary health care services are key spaces in which people
learn self-management strategies.
In Australia’s health system clinical guidelines, health policies
and care pathways have been developed largely in relation to
single illnesses and are focussed on achieving optimum medical
outcomes for single conditions. The efficient use of patient time
may be taken into account, for example, in cycles of care
guidelines for people with diabetes that optimise the time period
between various tests (Diabetes Australia 2009 National Evidence
Based Guidelines for the Management of Type 2 Diabetes).
However, when multiple care pathways are brought into play
because a patient has multi-morbidity, the impact on patient time
will be quantitatively and perhaps qualitatively different.
The social value of time has been addressed by other research
[29], and is not addressed in this study. However we do explore
the quantum of time used by people with multi-morbidity to allow
some consideration of its impact on their lives. The aim of this
study was to quantify the time people with multi-morbidity spend
on HRA and its relationship with the number of chronic illnesses
using data from The Serious and Continuing Illness Policy and
Practice Study (SCIPPS), an Australian study that included
research on time use and coordination.
Methods
The survey built on an earlier qualitative study of 61 patients
and 17 informal carers, living with chronic illness in the western
suburbs of Sydney and the Australian Capital Territory [30,31].
The survey was piloted, revised, then mailed to the following
groups of older Australians: 5,000 members of National Seniors
Australia (NSA - a private body of Australians with 285,000
members aged 50 years and over); 2,500 registrants on the
National Diabetes Services Scheme (NDSS - a government funded
service which provides subsidies for diabetes materials with
280,000 registrants aged 50 years and over); and 3,100 members
who had chronic obstructive pulmonary disease (COPD) of the
Lung Foundation Australia (LFA - a private body which supports
people with lung conditions).
The sample drawn from NSA members was stratified by State
and age (50–64.65–74.75 years and over), with an oversampling of
older members to increase the proportions with chronic illness.
The sample of registrants aged 50 years or over from the NDSS
register, was stratified by State, age (50–59, 60–69,70–79, 80 years
and over) and gender with no oversampling as the scheme
operates specifically to subsidise costs for persons with diabetes.
Samples were selected using simple random sampling within each
stratum. All 3,062 members of Lung Foundation Australia with
COPD were surveyed. Estimates are weighted by stratum response
rates, and analyses undertaken separately for each sub-sample.
The rationale behind this complex sampling framework was
that NSA respondents may provide an overview of the problem in
the elderly, whereas NDSS targets patients with diabetes,
a condition usually associated with co-morbidity [1]. The LFA
also provides an illness-specific focus. For ease of reading we use
the terms ‘COPD sub-sample’ to reference the LFA sample, and
‘Diabetes sub-sample’ to reference the NDSS sample.
Ethics Statement
Ethics approval for the survey was obtained from the Australian
National University Human Research Ethics Committee (Protocol
number: 2010/468) in 2010. All respondents provided informed
consent to participate by returning completed questionnaires. As
well as taking care over the issues of confidentiality and consent,
we were at pains to avoid any additional time burden on the
respondents. We therefore tested the length of the questionnaire in
the pilot.
Data Collection
A questionnaire collected data on time use (see Attachment S2).
Recall questionnaires were used in this study rather than diaries to
limit the burden of the research on the respondents and to
encourage response [32,33,34]. Time use was defined as the time
reportedly spent on any activity in three groups of health-related
activities:
1. Activities related to use of medical and allied health services in
the previous month; such as making appointments, travelling to
health services, waiting in waiting rooms, attending appoint-
ments and having medical treatments. These activities are
referred to as ‘clinic activities’.
2. Activities related to obtaining information, support or products
in the previous month; including attending rehabilitation
programs, education programs and support groups, shopping
for special foods and looking for/reading health information.
These activities are referred to as ‘other activities’.
3. Activities undertaken in domestic spaces on most days (such as
time spent on exercising, preparing/consuming prescribed
medications, and undertaking tests at home such as blood
glucose monitoring). These activities are referred to as ‘home
activities’.
The questionnaire also collected data on a range of de-
mographic and other variables including whether people lived in
major cities, regional or remote areas, and self-reported use of
health services. Australia is a large country where most people live
in major cities. The number of chronic conditions was also self-
reported, a well-established method for the measurement of multi-
morbidity [35]. Respondents were asked ‘Has a doctor ever told
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you that you had any of the following illnesses?’ This was followed
by the list of conditions in Table A in File S1 (see also Attachment
S1) and allowed for other conditions to be reported under ‘other’.
Analysis
Results are presented in terms of hours per month on each
grouped activity. As the distribution of time use is highly skewed,
results are presented using medians. In order to examine the
groups with the highest time use we also examined the time spent
by individuals in the top decile of time use. The measure of total
time used here excludes exercise unless otherwise stated. While the
majority of respondents spent some time on HRA, many people
did not spend time on every specific HRA included in the survey
(e.g. attending rehabilitation, preparing special foods). When
reporting on more detailed components of time use, we therefore
report on both the proportion of people undertaking these tasks,
and time spent by those undertaking them. Standard errors and
confidence intervals were derived using bootstrapping techniques




Overall 2,540 responses were received reflecting an overall
response rate of 24.0%, with 427 respondents in the Diabetes sub-
sample (16.8% response), 681 in the COPD sub-sample (22.0%
response), and 1,432 in the NSA sub-sample (28.4% response).
More details of the response rates are shown in Attachment S2.
Details of the socio-demographic and chronic condition char-
acteristics of the three sub-samples (weighted for non-response) are
shown in Table A in File S1. As expected almost all (94%) of the
members of the Diabetes sub-sample reported that they had
diabetes and almost all (90%) of the members of the COPD sub-
sample reported having COPD. Of the more general NSA
population over 40% had hypertension, 35% had arthritis, and
over a quarter reported having ever had cancer. Respondents
from the COPD and Diabetes sub-samples had on average more
co-morbid conditions than the NSA sub-sample (mean number of
chronic conditions is 3.7 for the COPD sub-sample, 3.4 for the
Diabetes sub-sample and 2.0 for the NSA sub-sample, with
COPD/Diabetes difference significant (p = 0.010) and other
differences highly significant (p,0.001)). The Diabetes and COPD
sub-samples were also prescribed more medications than respon-
dents in the NSA sub-sample (with mean values 4.8, 4.3 and 2.5
respectively, and all differences significant with p,0.001).
Time Spent on HRA
The time spent on HRA by people in the different demographic
and health categories is shown in Table B in File S1 (respondents
who spent no time on HRA are included). The reported total
median time use per month on HRA excluding exercise was 11.1
hours (95% confidence interval (CI) of 9.3–12.8 hours) for the
Diabetes sub-sample, 16.5 (14.7–18.3) hours per month for the
COPD sub-sample, and 5.2 (4.7–5.6) hours per month for the
NSA sub-sample.
There are few significant differences in time use between age,
region, qualifications and income categories although some weak
patterns are apparent. The one really clear set of statistically
significant time relationships across all three sub-samples is with
number of conditions. The number of conditions is related to time
use in all sub-samples and is highly significant in all sub-samples
(p,0.001 using the Cuzick test for trend [37]). An alternate view
of health care complexity is to look at the number of medications
taken, particularly since some of the time components relate to
medication management. The patterns are broadly in the
expected direction for the targeted samples, with the unexpected
values for those in small sample categories, and the Cuzick test
again shows a very strong relationship (p,0.001) between number
of medications and time reported for each sample.
Components of HRA
As shown in Table C in File S1 almost all respondents spent
some time on HRA. People in the COPD sub-sample were most
likely to spend time on HRA (97.8% for COPD sub-sample,
95.1% for Diabetes sub-sample and 92.6% for NSA sub-sample).
Time use was significantly the highest in the COPD sub-sample
(p = 0.017 compared the Diabetes sub-sample and p,0.001
compared with NSA sub-sample). The median time spent on
HRA by those who spent time on it was also significantly higher
(p,0.001 compared to both other both samples) for the COPD
sub-sample (17.5 hours per month) than the Diabetes sub-sample
(12.25 hours per month) or the NSA sub-sample (6.0 hours per
month).
Table C in File S1 also shows that, excluding exercise, median
time spent by all people in the COPD sub-sample (i.e. including
those with zero time) and the Diabetes sub-sample on daily home
activities was significantly higher (p,0.001) than the time spent on
clinical activities or ‘other’ activities. People in the Diabetes sub-
sample spent 6.0 hours in the past month on daily activities
compared to 1.7 hours on clinic activities. People in the COPD
sub-sample spent 7.5 hours on daily activities compared to 3.0
hours on clinic activities. People in the NSA sub-sample spent the
same amount of time on daily activities as on clinic activities, but
spent less time on the ‘other’ activities. People in the NSA sub-
sample were less likely to spend time on all categories than people
in the other sub-samples (with differences significant at p,0.001)
except the estimated clinic time use for the Diabetes sub-sample
and NSA sub-sample were not significantly different). For
example, the median time spent on daily activities was only 1.5
hours per month compared to the 6.0 and 7.5 hours per month
referred to above.
The reported total median hours (95% CI) on HRA including
exercise were 25.8 (22.0–29.5–) hours per month for the Diabetes
sub-sample, 31.2 (29.1–33.2) hours for the COPD sub-sample, and
21.7 (20.3–23.0) hours for the NSA sub-sample. Therefore,
exercise on average added 14–16 hours per month to median
activity, or around half an hour per day. It roughly doubled the
estimated median time spent on HRA for the targeted samples and
quadrupled it for the NSA sub-sample. Sixteen percent of the NSA
sub-sample undertook exercise but no other daily HRA, while
there were very few such people in the other samples as nearly all
were engaged in some other daily HRA.
Time Use for the Highest Time Users
To provide an alternate perspective, Table D in File S1
provides the distribution of times for each sub-sample. As can
be seen in Table D in File S1, 5.6% of those in the COPD
sample reported spending more than 100 hours per month on
HRA. Table E in File S1 provides the 90th percentile times
showing the total time used (excluding exercise) by the top 10%
of the population in each of these categories. The top 10% of
time users spent over 51.4 (43.0–59.8) hours per month in the
Diabetes sub-sample, over 62.6 (53.5–71.7) hours per month in
the COPD sub-sample, and over 34.1 (30.7–37.5) hours per
month in the NSA sub-sample on HRA. However, those people
with five or more conditions spent 30 to 40 hours per month
more than that, with those in the top quintile of the COPD
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sample who had five or more conditions spending more than
109.5 (85.7–133.3) hours per month which is equivalent to 3.5
hours per day on managing their conditions.
Discussion
This study has been the first to quantify the time spent on
HRA by older Australians with multi-morbidity. The study
found that the more chronic illnesses a person had the more
time they spent managing their health (especially if they had
COPD). Median total time spent in the past month on HRA
(excluding exercise) was 16.5 hours for people in the COPD
sub-sample, 11.1 hours for people in the Diabetes sub-sample,
and 5.2 hours for people in the NSA sub-sample. People in the
top 10% of time use from the COPD sub-sample spent 62.6
hours per month or more on HRA, the top 10% of the
Diabetes sub-sample spent 51.4 hours per month or more, and
the top 10% of the NSA sub-sample spent 34.1 hours per
month. Within all sub-samples the time increased with
increasing co-morbidity, with estimates of 109.5, 80.1 and
71.5 hours per month for people with five or more conditions
in the COPD, Diabetes and NSA sub-samples respectively.
The significantly higher total time for the COPD sub-sample is
likely to be due to two factors; 1) that people in this sub-sample
had on average more conditions than those in the other sub-
samples, and 2) the time demands associated with COPD are
higher than many other conditions.
The number of prescribed medications a person takes is also
a major and significant determinant of time use, and while
numbers of conditions and numbers of medications are clearly
correlated they potentially have independent effects on time use.
These findings are consistent with our previous qualitative
research showing the constraints that multi-morbidity place on
the way people spend their time [30].
While the study shows median monthly time use of 5–16
hours per month overall for our three sub-samples, which are
not excessive time demands, the demands on those with multi-
morbidity become much larger, and people in the top decile of
those with five or more conditions face time demands (at the
median) equivalent to two to three hours per day. For people
with five or more conditions it may be reasonable to assume
that exercise is undertaken as part of self-management with
a view to optimising health, as many of these people will be
restricted by their multiple conditions. Under this assumption,
with exercise added the 90th percentile for people with 5 or
more conditions is another 30–40 hours per month –110.1
hours, 147.5 hours and 118.5 hours for the Diabetes, COPD
and NSA sub-samples respectively. These times are equivalent
to between 3.5 and almost five hours per day on average. This
means that people with the highest number of conditions in the
90th percentile were spending between 5.5 and eight hours each
day on HRA.
The study described the median times spent on HRA either
with health services or at home. A gradation of time use for HRA
was found with most of the time spent on home activities, followed
by time spent on clinic activities and the least time spent on ‘other’
health activities such as shopping for medicines or attending
rehabilitation.
While it is not surprising that the study shows that the factors
determining time use relate to health it is interesting that other
factors do not seem to be material (in particular whether the
person lives in a capital city or elsewhere – where travel time costs
might have been expected to be important).
Implications for Self-management Policy and Health
Service Delivery
This first study into time use on HRA undertaken by
Australians with chronic conditions has shown that illness
management occupies considerable time for those with multi-
morbidity. These data cannot identify how much of this time is
spent on activities which are unnecessary or inefficient (perhaps
due to lack of co-ordination). It is clear, however, that clinicians
assisting patients with multi-morbidity need to be aware of the
time demands made of patients. Options for reducing this demand
may include instigating better co-ordination for booking consulta-
tions, identifying methods for reducing waiting times, improving
support for self-management activities [38], and using straightfor-
ward strategies such as pre-packed blister packs for medications or
other dose administration aids (DOA). In Australia, pharmacists
can dispense medications in DOA, but at an additional cost to the
patient that is not presently covered by the Pharmaceutical
Benefits Scheme.
On a larger scale, under the current Australian health system
reform, strategies are underway to improve team care and care co-
ordination [11,39,40,41]. This study provides empirical evidence
of the importance of such strategies in terms of decreasing time
burdens on people with multi-morbidity. However, as Anstey and
colleagues have observed, some approaches to reducing time
burdens on both health professionals and patients can have
unintentional consequences and the drivers and facilitators of
change must be considered carefully. On this matter, Anstey
argues that approaches in Australia can learn a lot from those
undertaken in other health systems [41].
Finally, for a given level of multi-morbidity, some combinations
of illnesses are likely to be associated with higher levels of HRA
than others, depending on the concordance or discordance of the
illnesses [1]. This issue has not been addressed in this study, and as
there are not large differences between time use for particular
index illnesses, cluster analysis is likely to be a complex task and
will be addressed in a later report.
Study Limitations
This study had a relatively low response rate, and because of its
tripartite structure had relatively small samples in each group. It is
possible that people with poor health may have been deterred
from responding to the survey and if this is the case then the
reported time use may under-estimate the real costs. The Diabetes
and COPD sub-samples had lower response rates than the NSA
sub-sample. However, as shown in Attachment S1 while response
rates varied there were no obvious biases in the non-response, and
the usage of the separate samples permitted study of significant
numbers of people with diabetes and with COPD.
The study used a recall questionnaire rather than a time use
diary to minimize inconvenience to respondents and to extend the
period over which the time use could be explored. While there is
a known risk of inaccurate recall associated with questionnaires
[42] our recent literature review found that they have been utilised
in chronic illness research more often than diaries [43].
This study has demonstrated that the time people spend on
HRA is substantial and identified a strong gradient in time
demands and levels of illness. However, many questions remain
unanswered. An important question is how people prioritise their
health activities against other activities within the fixed amount of
time available each day. Deciding how much time to spend on
their health may depend on time scarcity, practical issues and
issues of personal prioritisation [44]. Those with multiple
conditions or disabilities may also find that they are very slow in
performing some of the tasks. Personal prioritisation may be used
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to make a conscious decision as to whether a social activity will be
attended rather than completing a health activity, and healthy
choices may yet be made in the social context, thus blurring the
lines of time spent on HRA. Russell and colleagues note that
‘‘some tasks are more important for certain patients than others’’
[34:55] and this study suggests that further more detailed work is
required to understand how these decisions are taken.
The study has not captured fluctuations of time use associated
with the trajectory of particular conditions. Nor, as also noted
above, did the study capture the opportunity costs; the social time
costs that are incurred through the chronic illness time costs [14].
To address these problems qualitative research should be un-
dertaken, exploring which options are available to people
concerning their time use, which choices people make, and the
motivations behind such choices.
Conclusion
Increasing numbers of chronic conditions are significantly
associated with increasing time spent on HRA. On average,
people in this study who only had one chronic condition spent
between three and 13 hours each month on HRA, depending on
the sub-sample. However, people with five or more chronic
conditions spent on average between 16 and 27 hours each month
on HRA, depending on the sub-sample. For those in the top decile
of people with five or more chronic conditions in the COPD sub-
sample the time spent on HRA was as high as 110 hours per
month. Increasing numbers of prescribed medications is also
significantly associated with increasing time spent on HRA. We
suggest that in planning future self-management programs, health
care services and health policies, considerations be made in terms
of patient time use; the costs and benefits to people with multi-
morbidity, who may be experiencing significant constraints on
their time and changes to the way they use and experience that
time.
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